<DOC>
	<DOCNO>NCT01213498</DOCNO>
	<brief_summary>It document statin reduce mortality morbidity patient cardiovascular disease . This effect partly relate reduction cholesterol level blood . Nitric oxide ( NO ) production reduce several chronic disease nephropathy , diabetes hypertension . The purpose study investigate effect Atorvastatin treatment NO-system measure renal cardiovascular variable patient witk chronic kidney disease .</brief_summary>
	<brief_title>The Effects Atorvastatin Nitric Oxide-system Patients With Non-diabetic Nephropathy</brief_title>
	<detailed_description>Subjects examine two examination day . 4 day prior examination day subject treat either atorvastatin placebo . During treatment period subject give standardized diet . On examination day subject give L-NMMA ( L-NG-monomethyl Arginine citrate ) , NO inhibitor , 6 mg bolus infusion follow continuous 4 mg/kg/hr infusion 1 hour . Renal function , central hemodynamic vasoactive hormone evaluate prior , L-NMMA infusion . Renal function measure renal clearance 51Chromium-EDTA urinary sodium , potassium albumin concentration . Urinary excretion protein NCC , NKCC ENaC measure evaluate channel activity nephron . Central blood pressure , pulse wave analysis , augmentation index measure use SphygmoCorÂ® Atcor .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>Men woman minimum 20 year Chronic Kidney disease Estimated GFR ( eGFR ) 30 90 ml/min Nephrotic Syndrome Diabetes mellitus Anamnestic clinical sign significant heart , lung , lever , kidney , thyroid brain disease Neoplastic disease Alcohol abuse , Drug abuse Pregnancy nursing Blood donation within month examination Hgb &lt; 6,0</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Nephrology</keyword>
	<keyword>Atorvastatin</keyword>
	<keyword>L-NMMA</keyword>
	<keyword>NO</keyword>
</DOC>